Current Developments in Immunotherapy Markets and Technology

 
   Single User - $2,812


Loading...
Published Apr 1, 2001 | 357 Pages | Pub ID: KLI26

Special Offer: Now 25% off original sale price of $3750
Beyond congenital and acquired immune deficiencies immunotherapy is employed in a number of major disease areas such as hypersensitivity/allergy and cancer. The application in organ transplantation dealing with prevention of allograph rejection and transplantation sickness has long been known. This report from MarketResearch.com examines this market and provides forecasts to 2005 for major immunotherapy products including:
  • Corticosteroids
  • Cyclosporin and Related Immunosuppresives
  • NSAIDS
  • Gamma Globulins
  • Monoclonal Antibodies
  • Cytokines/Lymphokines
  • Immunizations and vaccines

In addition, the use of Genetic Manipulation for immunomodulation will be discussed in detail.

The report will present and detail advanced research efforts. Commercial efforts and strategic alliances will be clearly presented for the specific companies profiled in the report.

Chapter One
Executive Summary

  • Introduction
  • Scope And Methodology
  • Size And Growth Of Market
  • Market Trends
  • The Nature Of The Industry
  • The Applications
  • Cancer
  • Rheumatoid Arthritis
  • Hiv/Aids
  • Autoimmune Diseases
  • Allergy And Asthma
  • Vaccines

Chapter Two
Introduction

  • Background
  • Defining Immunotherapy
  • The Pros And Cons Of Immunotherapy
  • Point Of View

Chapter Three
Cancer Immunotherapy

  • Epidemiology
  • Market Population Trends
  • Cancer Prevalence Trends
  • Cancer Incidence Trends
  • Immunological And Vaccine Approaches
  • Market Overview
  • Immunotherapy Background
  • The Technological Basis For Cancer Immunotherapy
  • Cytokine Therapeutics
  • Genetic Cytokine Stimulation
  • Cancer Vaccines
  • Modified Antibodies
  • Alternative Approaches To Cancer Immunotherapy
  • Progress In Cancer Immunotherapy
  • Limitations Of Immune Therapy
  • The Commercial Outlook

Chapter Four
Rheumatoid Arthritis

  • Background And Epidemiology
  • Market Overview
  • Immunotherapy Approaches
  • Commercial Outlook

Chapter Five
Hiv/Aids

  • Background And Epidemiology
  • Market Overview
  • Immunotherapy Approaches
  • Commercial Outlook

Chapter Six
Autoimmune Diseases

  • Background And Epidemiology
  • Multiple Sclerosis Myasthenia Gravis
  • Scleroderma
  • Systemic Lupus Erythematosus
  • Market Overview
  • Immunotherapy Approaches
  • Commercial Outlook

Chapter Seven
Allergy And Asthma

  • Background And Epidemiology
  • Market Overview
  • Immunotherapy Approaches
  • Commercial Outlook

Chapter Eight
Vaccines

  • Background And Epidemiology
  • Market Overview
  • Immunotherapy Approaches
  • Commercial Outlook

Chapter Nine
Company Profiles

  • Abgenix, Inc.
  • Amgen, Inc.
  • Argonex, Inc.
  • Autoimmune, Inc.
  • Biogen, Inc.
  • Biomira, Inc.
  • Centocor (Johnson & Johnson)
  • Corixa Corp.
  • Cypress Bioscience, Inc.
  • Genzyme Molecular Oncology
  • Igeneon Gmbh
  • Immunex, Inc.
  • Morphosys Ag
  • Vasogen, Inc.
  • Vertex Pharmaceuticals, Inc.
  • Vical, Inc.

Chapter Ten
Conclusions And Strategic Implications

Appendix A

Glossary

Appendix B

Company Names And Addresses

In this report, {{keyword[keywordTextProperty]}} appears {{keyword[keywordCountProperty]}} times. {{searchResults.STATRESULT.SUMMARY.KW[keywordTextProperty]}} appears {{searchResults.STATRESULT.SUMMARY.KW[keywordCountProperty]}} times.

We were unable to search inside this report.
No results matched your search criteria.

Search for an exact word or phrase by placing the word or phrase in quotation marks ("market trend"). Search for different versions or tenses of a word by placing an asterisk at the end of the word (pharma*).

Please note that your term must be at least three characters long and numbers will be blocked by the # sign.